Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cloudflare Inc (NET) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Cloudflare IncTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Cloudflare Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Cloudflare Inc trades at $319.37 (market cap $109.31B), while State Street SPDR S&P Biotech ETF trades at $159.34. The key difference: Cloudflare Inc is trading nearer its 52-week high, State Street SPDR S&P Biotech ETF nearer its low. Which is the better fit depends on your goals.

NETXBI
Market Cap
$109.31B
Sector
TechnologyBroad Market / Factor
52-Week High
$310.40$164.28
52-Week Low
$160.16$86.92
Enterprise Value
$108.67B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cloudflare Inc

Cloudflare (NET) trades at $310.40, up 3.37% on the day, and is near its 52-week high. The stock shows strong technical momentum with bullish moving averages, though RSI levels indicate potential overbought conditions. Fundamentally, revenue growth is robust at 36% year-over-year in Q2 2026, but the company remains unprofitable with a net margin of -8.21%. Recent news highlights AI-driven demand and a $2.175 billion convertible note offering.

The outlook is positive given analyst consensus and AI tailwinds, but high valuation multiples and persistent losses pose risks. Investment appeal hinges on sustained growth justifying premium pricing, while competition and execution challenges are key watchpoints for shareholders.

State Street SPDR S&P Biotech ETF

XBI trades at $159.15, up 0.71% with a bullish technical signal from moving averages. The biotech ETF shows strong momentum with a 17% monthly gain, driven by positive clinical data and M&A activity. Analyst coverage remains limited with a single hold rating, while institutional interest grows with recent $793,000 investment from Bay Colony Advisors.

Outlook remains positive given biotech sector resurgence, though elevated RSI suggests near-term overbought conditions. Key risks include sector volatility and regulatory uncertainty, but AI-driven drug discovery and strong pipeline developments provide growth catalysts for patient investors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cloudflare Inc

Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.

Read more on NET

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI